معرفی
Arnold Kristof serves as a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site and holds the position of Associate Professor in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University. He is affiliated with the Translational Research in Respiratory Diseases Program within the Centre for Translational Biology and the Department of Medicine, Division of Respiratory Medicine at the McGill University Health Centre (MUHC).
Dr. Kristof's research primarily focuses on mTOR (mammalian target of rapamycin) signaling pathways in respiratory diseases, particularly lymphangioleiomyomatosis (LAM) and acute lung injury. His work investigates how mTOR regulates cellular processes including growth, division, survival, and stress responses, with specific attention to how dysregulation contributes to lung pathologies. His research integrates molecular biology, cellular physiology, and translational approaches to develop better diagnostic and therapeutic strategies for patients with respiratory conditions.
Analysis of his publication record reveals a sustained research trajectory spanning three decades with recent publications (2023-2025) emphasizing critical care nutrition, molecular mechanisms of lung injury, and precision medicine approaches to respiratory diseases. His work increasingly incorporates multi-omics approaches, advanced disease modeling, and clinical translation of basic science findings. Key thematic areas include mTOR signaling in LAM pathogenesis, nutritional interventions in critical illness, and molecular diagnostics for respiratory conditions.
Dr. Kristof maintains an active research program with multiple clinical trials and collaborative projects, particularly within the Canadian Critical Care Trials Group framework. His work demonstrates strong integration between basic science investigations and clinical applications, with particular emphasis on developing targeted therapies for rare respiratory disorders.
